Strata Critical Medical, Inc.
SRTA
$4.14
-$0.11-2.59%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 197.14M | 166.74M | 153.51M | 149.61M | 146.82M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 197.14M | 166.74M | 153.51M | 149.61M | 146.82M |
| Cost of Revenue | 156.02M | 132.27M | 123.14M | 118.18M | 117.23M |
| Gross Profit | 41.13M | 34.47M | 30.36M | 31.43M | 29.59M |
| SG&A Expenses | 51.13M | 52.60M | 54.88M | 48.85M | 49.44M |
| Depreciation & Amortization | 2.60M | 1.26M | 1.26M | 1.26M | 1.26M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 209.75M | 186.46M | 179.57M | 168.43M | 167.92M |
| Operating Income | -12.61M | -19.71M | -26.06M | -18.82M | -21.11M |
| Income Before Tax | -20.07M | -22.11M | -18.08M | -15.35M | -16.16M |
| Income Tax Expenses | -17.00K | -17.00K | -17.00K | -17.00K | -84.00K |
| Earnings from Continuing Operations | -20.07 | -22.11 | -18.08 | -15.42 | -16.16 |
| Earnings from Discontinued Operations | 63.63M | 64.71M | 1.31M | 1.31M | 1.31M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 41.35M | 40.39M | -18.98M | -26.57M | -27.31M |
| EBIT | -12.61M | -19.71M | -26.06M | -18.82M | -21.11M |
| EBITDA | -5.71M | -14.75M | -20.24M | -13.21M | -15.60M |
| EPS Basic | 0.50 | 0.48 | -0.24 | -0.34 | -0.35 |
| Normalized Basic EPS | -0.03 | -0.12 | -0.17 | -0.11 | -0.12 |
| EPS Diluted | 0.50 | 0.47 | -0.24 | -0.34 | -0.36 |
| Normalized Diluted EPS | -0.03 | -0.12 | -0.17 | -0.11 | -0.12 |
| Average Basic Shares Outstanding | 327.65M | 321.50M | 317.09M | 313.18M | 309.09M |
| Average Diluted Shares Outstanding | 327.65M | 321.50M | 317.09M | 313.18M | 309.09M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |